Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-01-05

Clinical Trial Update: Oxytocin Substitution Therapy in Patients With Central Diabetes Insipidus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oxytocin substitution therapy for central diabetes insipidus; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Central Diabetes Insipidus (cDI) | Phase 2 | Status: RECRUITING